Skip to main content
SpringerLink
Log in

The Dopamine Transporter in Human Brain

Characterization and Effect of Cocaine Exposure

  • Chapter
Neurotransmitter Transporters

Part of the book series: Contemporary Neuroscience ((CNEURO))

Abstract

Deaths involving psychoactive drugs stem not only from overdose, but also from drug-induced mental states that may lead to serious injuries (9). Mortality data have revealed the virulence of the cocaine epidemic, although other indicators, including crime, drug-exposed neonates, drug-related traffic accidents, and drug use by workers, provide a more extensive view of the nature and extent of the problem of cocaine abuse. The arrival of inexpensive smokable crack cocaine has radically changed the nature of the epidemic and revealed the great addictive potential of this drug.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Alburges, M. E., Narang, N., and Wamsley, J. K. Alterations in the dopaminergic receptor system after chronic administration of cocaine. Synapse 14 (1993) 314–323.

    Article  PubMed  CAS  Google Scholar 

  2. Adolfsson, R., Gottfries, C.-G., Roos, B.-E., and Winblad, B. Post-mortem distribution of dopamine and homovanillic acid in human brain, variations related to age, and a review of the literature. J. Neural Transm. 45 (1979) 81–105.

    Article  PubMed  CAS  Google Scholar 

  3. Allard P. Questions about the dopaminergic nature of [3H]GBR 12935 binding in the human frontal cortex. J. Neurochem. 63 (1994) 1182, 1183.

    Google Scholar 

  4. Allard, P. and Marcusson, J. O. Age-correlated loss of dopamine uptake sites with [3H]GBR 12935 in human putamen. Neurobiol. Aging 10 (1989) 661–664.

    Article  PubMed  CAS  Google Scholar 

  5. Allard, P., Marcusson, J. O., and Ross, S. B. [3H]GBR 12935 binding to cytochrome P450 in the human brain. J. Neurochem. 62 (1994) 342–348.

    Article  PubMed  CAS  Google Scholar 

  6. Allard, P., Danielsson, M., Papworth, K., and Marcusson, J. O. [3H]GBR 12935 binding to human cerebral cortex is not to dopamine uptake sites. J. Neurochem. 62 (1994) 338–341.

    Article  PubMed  CAS  Google Scholar 

  7. Aloyo, V. J., Harvey, J. A., and Kirifides, A. L. Chronic cocaine increases WIN 35,428 binding in rabbit caudate. Soc. Neurosci. Abstr. 19 (1993) 1843.

    Google Scholar 

  8. Aquilonius, S. M., Bergstrom, K., Eckernas, S. A., Hartvig, P., Leenders, K. L., Lundquist, H., Antoni, G., Gee, A., Rimland, A., Uhlin, J., and Langstrom, B. In vivo evaluation of striatal dopamine reuptake sites using 11C-nomifensine and positron emission tomography. Acta Neurol. Scand. 76 (1987) 283–287.

    Article  PubMed  CAS  Google Scholar 

  9. Baker S. P. The Injury Fact Book. 2nd ed. Oxford University Press, New York, 1992.

    Google Scholar 

  10. Bannon, M. J., Poosch, M. S., Xia, Y., Goebel, D. J., Cassin, B., and Kapatos, G. Dopamine transporter mRNA content in human substantia nigra decreases precipitously with age. Proc. Natl. Acad. Sci. USA 89 (1992) 7095–7099.

    Article  PubMed  CAS  Google Scholar 

  11. Biegon, A., Dillon, K., Volkow, N. D., Hitzemann, R. J., Fowler, J. S., and Wolf, A. P. Quantitative autoradiography of cocaine binding sites in human brain postmortem. Synapse 10 (1992) 126–130.

    Article  PubMed  CAS  Google Scholar 

  12. Bjorklund, A. and Lindvall, O. Dopamine-containing systems in the CNS. In Bjorklund, A. and Hokfelt, T. (eds.) Handbook of Chemical Neuroanatomy, Vol. 2, Classical Transmitters in the CNS, Part I, Elsevier, New York, 1994, pp. 55–122.

    Google Scholar 

  13. Boja, J. W., Markham, L., Patel, A., Uhl, G., and Kuhar, M. J. Expression of a single dopamine transporter cDNA can confer two cocaine binding sites. Neuro. Rep. 3 (1992) 247, 248.

    Google Scholar 

  14. Boja, J. W. Vaughen, R., Patel A., Shaya, E. K., and Kuhar, M. J. The dopamine transporter. In Niznik, H. (ed.), Dopamine Receptors and Transporters. Dekker, New York (1994), pp. 611–644.

    Google Scholar 

  15. Buck, K. J. and Amara, S. G. Chimeric dopamine-norepinephrine transporters delineate structural domains influencing selectivity for catecholamines and 1methyl-4-phenylpyridinium. Proc. Natl. Acad. Sci. USA 91 (1994) 12,584–12,588.

    Google Scholar 

  16. Cook, C. E., Jeffcoat, A. R., and Perez-Reyes, M. Pharmacokinetic studies of cocaine and phencyclidine in man. In Barnett, G. and Chiang, C. N. (eds) Pharmacokinetics and Pharmacodynamics of Psychoactive Drugs, Biomedical, Foster City, CA, 1985, pp. 48–74.

    Google Scholar 

  17. Dackis, C. A. and Gold, M. S. Bromocriptine as a treatment of cocaine abuse. Lancet 1 (1985) 1151, 1152.

    Google Scholar 

  18. DeKeyser, J., Ebinger, G., and Vauquelin, G. Age-related changes in the human nigrostriatal dopaminergic system. Ann. Neurol. 27 (1990) 157–161.

    Article  CAS  Google Scholar 

  19. Ding, Y.-S., Fowler, J. S., Volkow, N. D., Gatley, S. J., Logan, J., Dewey, S. L., Alexoff, D., Fazzini, E., and Wolf, A. P. Pharmacokinetics and in vivo specificity of [11C]d1-threo-methylphenidate for the presynaptic dopaminergic neuron. Synapse 18 (1994) 152–160.

    Article  PubMed  CAS  Google Scholar 

  20. Dorman, G. A., Kaczmarczyk, S. J., Paxinos, G., Chilco, P. J., Kalnins, R. M., Woodhouse, D. G., and Mendelsohn, F. A. O. Distribution of catecholamine uptake sites in human brain as determined by quantitative [3H]mazindol autoradiography. J. Comp. Neurol. 304 (1991) 419–434.

    Article  Google Scholar 

  21. Eshleman, A. J., Neve, R. L., Janowsky, A., and Neve, K. A. Characterization of a recombinant human dopamine transporter in multiple cell lines. J. Pharm. Exp. Thera p. 274 (1995) 276–283.

    CAS  Google Scholar 

  22. Farde, L., Halldin, C., Muller, L., Suhara, T., Karlsson, P., and Hall, H. PET Study of [11C]3-CIT binding to monoamine transporters in the monkey and human brain. Synapse 16 (1994) 93–103.

    Article  PubMed  CAS  Google Scholar 

  23. Farfel, G. M., Kleven, M. S., Woolverton, W. L., Seiden, L. S., and Perry, B. D. Effects of repeated injections of cocaine on catecholamine receptor binding sites, dopamine transporter binding sites and behavior in rhesus monkey. Brain Res. 578 (1992) 235–243.

    Article  PubMed  CAS  Google Scholar 

  24. Fowler, J. S., Volkow, N. D., Wolf, A. P., Dewey, S. L., Schyler, D. J., Macgregor, R. R., Hitzemann, R., Logan, J., Bendrien, B., Gatley, S. J., and Christman, D. Mapping cocaine binding sites in human and baboon brain in vivo. Synapse 4 (1989) 371–377.

    Article  PubMed  CAS  Google Scholar 

  25. Galloway, M. P. Neurochemical interactions of cocaine with the dopaminergic system. Trends Pharmacol. Sci. 9 (1988) 451–454.

    Article  PubMed  CAS  Google Scholar 

  26. Gatley, S. J., Volkow, N. D., Fowler, J. S., Dewey, S. L., and Logan, J. Sensitivity of striatal [11C]cocaine binding to decreases in synaptic dopamine. Synapse 20 (1995) 137–144.

    Article  PubMed  CAS  Google Scholar 

  27. Gawin, F. H. and Ellinwood, E. H. Cocaine and other stimulants. N. Engl. J. Med. 318 (1988) 1173–1182.

    Article  PubMed  CAS  Google Scholar 

  28. Gerlernter, J., Kranzler, H. R., Satel, S. L., and Rao, P. A. Genetic association between dopamine transporter protein alleles and cocaine-induced paranoia. Neuropsychopharmacology 11 (1994) 195–200.

    Article  Google Scholar 

  29. Giros, B. and Caron, M. G. Molecular characterization of the dopamine transporter. Trends Pharmacol. Sci. 14 (1993) 43–49.

    Article  PubMed  CAS  Google Scholar 

  30. Giros, B., Mestikawy, S. E., Godinot, N., Zheng, K., Han, H., Yan-Feng, T., and Caron, M. G. Cloning, pharmacological characterization and chromosome assignment of the human dopamine transporter. Mol. Pharm. 42 (1992) 383–390.

    CAS  Google Scholar 

  31. Giros, B., Wang, Y. M., Suter, S., McLeskey, S. B., Pifl, C., and Caron, M. G. Delineation of discrete domains for substrate, cocaine, and tricyclic antidepressant interactions using chimeric dopamine-norepinephrine transporters. J. Biol. Chem. 269 (1994) 15,985–15,988.

    Google Scholar 

  32. Graybiel, A. M. and Moratalla, R. Dopamine uptake sites in the striatum are distributed differentially in striosome and matrix compartments. Proc. Natl. Acad. Sci. 86 (1989) 9020–9024.

    Article  PubMed  CAS  Google Scholar 

  33. Graybiel, A. M. and Ragsdale, C. W. Histochemically distinct compartments in the striatum of human, monkey and cat demonstrated by acetylcholinesterase staining. Proc. Natl. Acad. Sci. USA 75 (1978) 5723–5726.

    Article  PubMed  CAS  Google Scholar 

  34. Hitri, A., Casanove, M. F., Kleinman, J. E., Weinberger, D. R., and Wyatt, R. J. Age-related changes in [3H]GBR 12935 binding site density in the prefrontal cortex of controls and schizophrenics. Biol. Psych. 37 (1995) 175–182.

    Article  CAS  Google Scholar 

  35. Hitri, A., Hurd, Y. L., Wyatt, R. J., and Deutsch, S. I. Molecular, functional, and biochemical characteristics of the dopamine transporter: regional differences and clinical relevance. Clin. Neuropharm. 17 (1994) 1–22.

    Article  CAS  Google Scholar 

  36. Hitri, A., Venable, D., Nguyen, H. Q., Casanova, M. F., Kleinman, J. E., and Wyatt, R. J. Characteristics of [3H]GBR 12935 binding in the human and rat frontal cortex. J. Neurochem. 56 (1991) 1663–1672.

    Article  PubMed  CAS  Google Scholar 

  37. Hitri, A. and Wyatt, R. J. Questions about the dopaminergic nature of [3H]GBR 12935 binding in the human frontal cortex. J. Neurochem. 63 (1994) 1181–1182.

    PubMed  CAS  Google Scholar 

  38. Hornykiewicz O. Dopamine changes in the aging human brain. In Agnoli, A., Grepaldi, G., Spano P. F., and Trabucchi, M. (eds.) Aging Brain and Ergot Alkaloids, Vol. 23, Raven, New York, 1983, pp. 9–14.

    Google Scholar 

  39. Hurd, Y. L. and Herkanham, M. Molecular alterations in the neostriatum of human cocaine addicts. Synapse 13 (1993) 357–369.

    Article  PubMed  CAS  Google Scholar 

  40. Hurd, Y. L., Pristupa, Z. B. Herman, M. M., Niznik, H. B., and Kleinman, J. E. The dopamine transporter and dopamine D2 receptor messenger RNAs are differentially expressed in limbic-and motor-related subpopulations of human mesencephalic neurons. Neuroscience 63 (1994) 357–362.

    CAS  Google Scholar 

  41. Izenwasser, S. and Cox, B. M. Daily cocaine treatment produces a persistent reduction of [3H]dopamine uptake in vitro in rat nucleus accumbens but not in the striatum. Brain Res. 531 (1990) 338–341.

    Article  PubMed  CAS  Google Scholar 

  42. Katz, J. L., Griffiths, J. W., Sharpe, L. G., De Souza, E. B., and Witkin, J. M. Cocaine tolerance and cross-tolerance. J. Pharm. Exp. Ther. 264 (1993) 183–192.

    CAS  Google Scholar 

  43. Kaufman, M. J. and Madras, B. K. Severe depletion of cocaine recognition sites associated with the dopamine transporter in Parkinson’s diseased striatum. Synapse 9 (1991) 43–49.

    Article  PubMed  CAS  Google Scholar 

  44. Kitayama, S., Shimada, S., Xu, H., Markham, L., Donovan, D. M., and Uhl, G. R. Dopamine transporter site-directed mutations differentially alter substrate transport and cocaine binding. Proc. Natl. Acad. Sci. USA 89 (1992) 7782–7785.

    Article  PubMed  CAS  Google Scholar 

  45. Kitayama, S., Wang, J.-B., and Uhl, G. R. Dopamine transporter mutants selectively enhance MPP+ transport. Synapse 15 (1993) 58–62.

    Article  PubMed  CAS  Google Scholar 

  46. Kleber, H. D. Pharmacotherapy, current and potential, for the treatment of cocaine dependence. Clin. Neuropharm. 18 (1995) S96 - S109.

    Article  Google Scholar 

  47. Kleven, M. S., Woolverton, W. L., and Seiden, L. S. Lack of long-term monoamine depletions following repeated or continuous exposure to cocaine. Brain. Res. Bull. 21 (1988) 233–237.

    Article  PubMed  CAS  Google Scholar 

  48. Koff, J. M., Shuster, L., and Miller, L. G. Chronic cocaine administration is associated with behavioral sensitization and time-dependent changes in striatal dopamine transporter binding. J. Pharm. Exp. Ther. 268 (1994) 277–282.

    CAS  Google Scholar 

  49. Kuhar, M. J., Ritz, M. C., and Boja, J. W. The dopamine hypothesis of the reinforcing properties of cocaine. TINS 14 (1991) 299–302.

    CAS  Google Scholar 

  50. Kuikka, J. T., Akerman, K., Bergstrom, K. A., Karhu, J., Hiltunen, J., Haukka, J., Heikkinen, J., Tiihonen, J., Wang, S., and Neumeyer, J. L. Iodine-123 labelled N(2-fluoroethyl)-2 3-carbomethoxy-3[3-(4-iodophenyl)nortropane for dopamine transporter imaging in the living human brain. Eur. J. Nuc. Med. 22 (1995) 682–686.

    Article  CAS  Google Scholar 

  51. Kuikka, J. T., Bergstrom, K. A., Ahonen, A., Hiltunen, J., Haukka, J., Lansimies, E., Wang, S., and Neumeyer, J. L. Comparison of iodine-123 labelled 213-carbomethoxy-3ß-(4-iodophenyl)tropane and iodine-123 labelled 2(3-carbomethoxy3[3-(4-iodophenyl)-N-(3-fluoropropyl)nortropane for imaging of the dopamine transporter in the living human brain. Eur. J. Nuclear Med. 22 (1995) 356–360.

    Article  CAS  Google Scholar 

  52. Kula, N. S. and Baldessarini, R. J. Lack of increase in dopamine transporter binding or function in rat brain tissue after treatment with blockers of neuronal uptake of dopamine. Neuropharmacology 30 (1991) 89–92.

    Article  PubMed  CAS  Google Scholar 

  53. Kumor, K. Sherer M., and Jaffe, J. Haloperidol-induced dystonia in cocaine addicts. Lancet ii (1986) 1341, 1342.

    Google Scholar 

  54. Little, K. Y., Carroll, F. I., and Cassin, B. J. Characterization and localization of [125I]RTI-121 binding sites in human striatum and medial temporal lobe. J. Pharmacol. Exp. Ther. 274 (1995) 1474–1483.

    Google Scholar 

  55. Little, K. Y., Kirkman, J. A., Carroll, F. I., Breese, G. R., and Duncan, G. E. [’251]RTI-55 bindng to cocaine-sensitive dopaminergic and serotonergic uptake sites in the human brain. J. Neurochem. 61 (1993) 1996–2006.

    Article  PubMed  CAS  Google Scholar 

  56. Little, K. Y., Kirkman, J. A., Carroll, F. I., Clark, T. B., and Duncan, G. E. Cocaine use increases [3H]WIN 35,428 binding sites in human striatum. Brain Res. 628 (1993) 17–25.

    Article  PubMed  CAS  Google Scholar 

  57. Lowenstein, P. R., Joyce, J. N., Coyle, J. T., and Marshall, J. F. Striosomal organization of cholinerigic and dopaminergic uptake sites and cholinergic M1 receptors in the adult human striatum: a quantitative receptor autoradiographic study. Brain Res. 510 (1990) 122–126.

    Article  PubMed  CAS  Google Scholar 

  58. Madras, B. K. and Kaufman, M. J. Cocaine accumulates in dopamine-rich region of primate brain after i.v. administration: comparison with mazindol distribution. Synapse 18 (1994) 261–275.

    Article  PubMed  CAS  Google Scholar 

  59. Madras, B. K., Spealman, R. D., Fahey, M. A., Neumeyer, J. L., Saha, J. K., and Milius, R. A. Cocaine receptors labeled by [3H]213-carbomethoxy-3 3-(4-fluorophenyl)tropane. Mol. Pharmacol. 36 (1989) 518–524.

    PubMed  CAS  Google Scholar 

  60. Malison, R. SPECT imaging of DA transporters in cocaine dependence with [’Z31]ß-CIT. NIDA Res. Monogr. 152 (1995) 60.

    Google Scholar 

  61. Marcusson J. and Ericksson K. [3H]GBR 12935 binding to dopamine uptake sites in the human brain. Brain Res 457 (1988) 122–129.

    Google Scholar 

  62. McGeer, P. L., McGeer, E. G., and Suzuki, J. S. Aging and extrapyramidal function. Arch Neurol. 34 (1977) 33–35.

    Article  PubMed  CAS  Google Scholar 

  63. Neumeyer, J. L., Wang, S., Gao, Y., Milius, R. A., Kula, N. S., Campbell, A., Baldessarini, R. J., Zea-Ponce, Y., Baldwin, R. M., and Innis, R. B. N-wFluoroalkyl analogs of (1R)-213-carbomethoxy-3ß-(4-iodophenyl)-tropane (13CIT): radiotracers for positron emission tomography and single photon emission tomography and single photon emission computed tomography imaging of dopamine transporters. J. Med Chem. 37 (1994) 1558–1561.

    Article  PubMed  CAS  Google Scholar 

  64. Niznik, H. B., Tyndale, R. F., Sallee, F. R., Gonzalez, F. J., Hardwick, J. P., Inaba, T., and Kalow, W. The dopamine transporter and cytochrome p450IIDI (debrisoquine 4-hydroxylase) in brain: resolution and identification of two distinct [3H]GBR 12935 binding proteins. Arch. Biochem. Biophys. 276 (1990) 424–432.

    Article  PubMed  CAS  Google Scholar 

  65. Penis, J., Boyson, S. J., Cass, W. A., Curella, R., Dwoskin, L. P., Larson, G., Lin, L.-H., Yasuda, R. P., and Zahinser, N. R. Persistence of neurochemical changes in dopamine systems after repeated cocaine administration. J. Pharmacol. Exp. Therap. 253 (1990) 38–44.

    Google Scholar 

  66. Pirker, W., Asenbaum, S., Kasper, S., Walter, H., Angellberger, P., Koc, G., Pozzera, A., Deecke, L., Podreka, I., and Brucke, T. ß-CIT SPECT demonstrates blockade of 5HT-uptake sites by citalopram in the human brain in vivo. J. Neural Transm. 100 (1995) 247–256.

    Article  CAS  Google Scholar 

  67. Pristupa, Z. B., Wilson, J. M., Hoffman, B. J., Kish, S. J., and Niznik, H. B. Pharmacological heterogeneity of the cloned and native human dopamine transporter: dissociation of [3H1WIN 35,428 and [3H]GBR 12935 binding. Mol. Pharm. 45 (1994) 125–135.

    CAS  Google Scholar 

  68. Reith, M. E. A., De Cosata, B., Rice, K. C., and Jacobsen, A. E. Evidence for mutually exclusive binding of cocaine, BTCP, GBR 12935, and dopamine to the dopamine transporter. Eur. J. Pharmacol. 227 (1992) 417–425.

    CAS  Google Scholar 

  69. Reith, M. E. A. and Selmeci, G. Radiolabeling of dopamine uptake sites in mouse striatum—comparision of bindings sites for cocaine, mazindol, and GBR 12935. Naunyn-Schmeidebergs Arch. Pharmacol. 345 (1992) 309–318.

    Article  CAS  Google Scholar 

  70. Ritz, M. C., Lamb, R. J., Goldberg, S. R., and Kuhar, M. J. Cocaine receptors of dopamine transporters are related to self-administration of cocaine. Science 237 (1987) 1219–1223.

    Article  PubMed  CAS  Google Scholar 

  71. Rothman, R. B. High affinity dopamine reuptake inhibitors as potential cocaine antagonists: a strategy for drug development. Life Sci 46 (1990) PL17–PL21.

    Google Scholar 

  72. Salmon, E., Brooks, D. J., Leenders, K. L., Turton, D. R., Hume, S. P., Cremer, J. E., Jones, T., and Frackowiak, R. S. J. A two-compartment description and kinetic procedure for measuring regional cerebral [11C]nomifensine uptake using positron emission tomography. J. Cereb. Blood Flow Metab. 10 (1990) 307–316.

    Article  PubMed  CAS  Google Scholar 

  73. Satel, S. L. and Swann, S. C. Extrapyramidal symptoms and cocaine abuse. Am. J. Psychiat. 150 (1993) 347.

    PubMed  CAS  Google Scholar 

  74. Schweri, M. M. Rapid increase of stimulant binding to the dopamine transporter after acute cocaine administration: physiological basis of drug craving. Soc. Neurosci. Abstr. 19 (1993) 936.

    Google Scholar 

  75. Seibyl, J. P., Wallace, E., Smith, E. O., Stabin, M., Baldwin, R. M., Zoghbi, S., Zea-Ponce, Y., Gao, Y., Zhang, W. Y., Neumeyer, J. L., Zubal, G., Charney, D. S., Hoffer, P. B., and Innis, R. B. Whole-body biodistribution, radiation absorbed dose and brain SPECT imaging with iodine-123-CIT in healthy human subjects. J. Nuclear Med. 35 (1994) 764–770.

    CAS  Google Scholar 

  76. Sharpe, L. G., Pilotte, N. S., Mitchell, W. M., and De Souza, E. B. Withdrawal of repeated cocaine decreases autoradiographic [3H]mazindol-labelling of dopamine transporter in rat nucleus accumbens. Eur. J. Pharm. 203 (1991) 141–144.

    Article  CAS  Google Scholar 

  77. Staley, J. K., Basile, M., Flynn, D. D., and Mash, D. C. Visualizing dopamine and serotonin transporters in the human brain with the potent cocaine analogue [’25I]RTI-55: In vitro binding and autoradiographic characterization. J. Neurochem. 62 (1994) 549–556.

    Article  PubMed  CAS  Google Scholar 

  78. Staley, J. K., Basile, M., Wetli, C. V., Hearn, W. L., Flynn, D. D., Ruttenber, A. J., and Mash, D. C. Differential regulation of the dopamine transporter in cocaine overdose deaths. NIDA Res. Monogr. 141 (1994) 32.

    Google Scholar 

  79. Staley, J. K., Hearn, W. L, Ruttenber, A. J., Wetli, C. V., and Mash, D. C. High affinity cocaine recognition sites on the dopamine transporter are elevated in fatal cocaine overdose victims. J. Pharm. Exp. Therap. 271 (1995) 1678–1685.

    Google Scholar 

  80. Staley, J. K., Wetli, C. V., Ruttenber, A. J., Hearn, W. L., and Mash, D. C. Altered dopaminergic synaptic markers in cocaine psychosis and sudden death. NIDA Res. Monogr. 153: 491 (1995).

    Google Scholar 

  81. Staley, J. K., Boja, J. W., Carroll, F. I., Seltzman, H. H., Wyrick, C. D., Lewin, A. H., Abraham, P., and Mash, D. C. Mapping dopamine transporters in the human brain with novel selective cocaine analog [’25I]RTI-121. Synapse 21 (1995) 364–372.

    Article  PubMed  CAS  Google Scholar 

  82. Tedroff, J., Aquilonius, S. M., Hartvig, P., Lundquist, H., Gee, A. G., Uhlin, J., and Langstrom, B. Monoamine reuptake sites in the human brain evaluated in vivo by means of [11C]nomifensine and positron emission tomography: the effects of age and Parkinson’s disease. Acta Neurol. Scand. 77 (1988) 192–201.

    Article  PubMed  CAS  Google Scholar 

  83. Vandenbergh, S. J., Persico, A. M., and Uhl, G. R. A human dopamine transporter cDNA predicts reduced glycosylation, displays a novel repetitive element and provides racially-dimorphic Taq I RFLPS. Mol. Brain Res. 15 (1992) 161–166.

    Article  PubMed  CAS  Google Scholar 

  84. Van Dyck, C. H., Seibyl, J. P., Malison, R. T., Laruelle, M., Wallace, E., Zoghbi, S. S., Zea-Ponse, Y., Baldwin, R. M., Charney, D. S., Hoffer, P. B., and Innis, R. B. Age-related decline in striatal dopamine transporter binding with iodine123—CIT SPECT. J. Nuclear Med. 36 (1995) 1175–1181.

    Google Scholar 

  85. Volkow, N. D., Fowler, J. S., Logan, J., Wang, G.-J., Hitzemann, R., MacGregor, R., Dewey, S. L., and Wolf, A. P. Decreased binding of 11-C-cocaine in the brain of cocaine addicts. J. Nuclear Med. 33 (1992) 888.

    Google Scholar 

  86. Volkow, N. D., Fowler, J. S., Wang, G.-J., Logan, J., Schlyer, D., MacGregor, R. Hitzemann, R., and Wolf, A. P. Decreased dopamine transporters with age in healthy human subjects. Ann. Neurol. 36 (1994) 237–238.

    Article  PubMed  CAS  Google Scholar 

  87. Volkow, N. D., Ding, Y.-S., Fowler, J. S., Wang, G.-J., Logan, J., Gatley, J. S., Dewey, S., Ashby, C., Liebermann, J., Hitzemann, R., and Wolf, A. P. Is methylphenidate like cocaine? Arch. Gen. Psychiatry 52 (1995) 456–463.

    Article  PubMed  CAS  Google Scholar 

  88. Weiss, R. D. and Mirin, S. M. Psychological and pharmacological treatment strategies in cocaine dependence. Ann. Clin. Psych. 2 (1990) 239–243.

    Article  Google Scholar 

  89. Wetli, C. V. and Fishbain, D. A. Cocaine-induced psychosis and sudden death in recreational cocaine users. J. Foresci. Sci. 30 (1985) 873–880.

    CAS  Google Scholar 

  90. Wilson, J. M., Nobrega, J. N., Carroll, M. E., Niznik, H. B., Shannak, K., Lac, S. T., Pristupa, Z. B., Dixon, L. M., and Kish, S. J. Heterogenous subregional bind- ing patterns of 3H-WIN 35,428 and 3H-GBR 12,935 are differentially regulated by chronic cocaine self-adminstration. J. Neurosci. 14 (1994) 2966–2974.

    PubMed  CAS  Google Scholar 

  91. Wong, D. F., Yung, B., Dannals, R. F., Shaya, E. K., Ravert, H. T., Chen, C. A., Chan, B., Folio, T., Scheffel, U., Ricaurte, G. A., Neumeyer, J. L., Wagner, H. N., and Kuhar, M. J. In vivo imaging of baboon and human dopamine transporters by positron emission tomography using [“C]WIN 35,428. Synapse 15 (1993) 130–142.

    Article  PubMed  CAS  Google Scholar 

  92. Yi, S.-J. and Johnson, K. M. Effects of acute and chronic administration of cocaine on striatal uptake, compartmentalization and release of [3H]dopamine. Neuropharmacology 29 (1990) 475–486.

    Article  PubMed  Google Scholar 

  93. Zelnik, N., Angel, I., Paul, S. M., and Kleinman, J. E. Decreased density of human striatal dopamine uptake sites with age. Eur. J. Pharmacol. 126 (1986) 175, 176.

    Google Scholar 

Download references

Authors
  1. Deborah C. Mash
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Julie K. Staley
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. College of Medicine, University of Illinois, Peoria, IL, USA

    Maarten E. A. Reith

Rights and permissions

Reprints and permissions

Copyright information

© 1997 Springer Science+Business Media New York

About this chapter

Cite this chapter

Mash, D.C., Staley, J.K. (1997). The Dopamine Transporter in Human Brain. In: Reith, M.E.A. (eds) Neurotransmitter Transporters. Contemporary Neuroscience. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-470-2_11

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-470-2_11

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-4757-5980-8

  • Online ISBN: 978-1-59259-470-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation